239 filings
Page 4 of 12
8-K
moevx
7 May 20
Kadmon Provides Business Update and Reports First Quarter 2020 Financial Results
4:16pm
DEFA14A
oa0015smqeoljo0nku
2 Apr 20
Additional proxy soliciting materials
4:20pm
8-K
oevc 3t8cbkdts4t5
10 Mar 20
Departure of Directors or Certain Officers
4:15pm
8-K
3ndm6qj84h 54
5 Mar 20
Kadmon Highlights Recent Progress and Reports Fourth Quarter and Full Year 2019 Financial Results
4:15pm
8-K
4mv7f0 boco
24 Feb 20
Kadmon Announces Expanded Results of Interim Analysis of Pivotal Trial of KD025 in cGVHD
6:03am
8-K
cjyeevm5
19 Nov 19
Departure of Directors or Certain Officers
4:15pm
8-K
zmrd446l
14 Nov 19
Other Events
4:15pm
424B5
s5zby
14 Nov 19
Prospectus supplement for primary offering
4:12pm
424B5
52ej2ar51m u5
13 Nov 19
Prospectus supplement for primary offering
5:17pm
8-K
sv1vfciym6zt80qr9u
13 Nov 19
Kadmon Announces that KD025 Met Primary Endpoint at Interim Analysis of Pivotal Trial in Chronic Graft-Versus-Host Disease
12:00am
8-K
ry7e95w5w 1pk71
7 Nov 19
Kadmon Provides Business Update and Reports Third Quarter 2019 Financial Results
4:18pm
424B5
153b5fh
26 Sep 19
Prospectus supplement for primary offering
4:27pm
424B5
sdl9q3v0dv4
26 Sep 19
Prospectus supplement for primary offering
4:25pm
EFFECT
fvpei7ra
25 Sep 19
Notice of effectiveness
12:15am
CORRESP
anth9hc8gox9tohb55is
20 Sep 19
Correspondence with SEC
12:00am
UPLOAD
ifry7l
19 Sep 19
Letter from SEC
12:00am